RDY
Dr. Reddy's Laboratories Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IN
$14.74
+3.04%Forward multiples
Based on analyst estimates
- P/E forward
- 26.69x
- P/E 2026E
- 31.65x
- P/E 2027E
- 23.51x
- P/E 2028E
- 18.82x
- P/S forward
- 3.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- 41.07x
- PEG TTM
- 0.76x
- Price / book
- 3.00x
- Price / sales
- 3.51x
- Price / cash flow
- 38.64x
Enterprise value
- Enterprise value
- $12.3B
- EV / sales
- 3.51x
- EV / EBITDA
- 21.55x
- EV / EBIT
- 39.34x
- Market cap
- $12.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026